Wave Life Sciences Ltd.
Clinical trials sponsored by Wave Life Sciences Ltd., explained in plain language.
-
New hope for duchenne: drug targets missing protein
Disease control Recruiting nowThis study tests a drug called WVE-N531 in people with Duchenne muscular dystrophy (DMD), a genetic condition that causes muscle weakness. The drug aims to help the body produce a protein called dystrophin, which is missing in DMD. About 26 participants will receive the drug thro…
Phase: PHASE1, PHASE2 • Sponsor: Wave Life Sciences Ltd. • Aim: Disease control
Last updated May 14, 2026 12:04 UTC
-
New weight loss drug WVE-007 enters early human testing
Disease control Recruiting nowThis early-stage study is testing a new drug called WVE-007 in 136 adults with overweight or obesity (BMI 28-35). The main goal is to check if the drug is safe and how the body handles it. Participants will receive either the drug or a placebo as a single injection, and researche…
Phase: PHASE1 • Sponsor: Wave Life Sciences Ltd. • Aim: Disease control
Last updated May 04, 2026 16:21 UTC